Abridge vs Microsoft Dragon Copilot
The two enterprise scribes most health systems actually shortlist, and they publish opposite things. Dragon Copilot publishes the most complete documentation set in this category, a transparency white paper that names its own failure modes including hallucinated details in summarization and underperformance on accents and dialects, alongside a sub processor list and separate privacy and security papers. Abridge publishes buyer facing assurance instead, a full trust centre carrying SOC 2 Type 2, TX-RAMP and published accessibility conformance, plus the strongest adoption record in the lane. The randomized evidence complicates the incumbent case: in the first controlled trial of ambient scribes the Dragon arm reduced time in note by 1.7 percent and did not meet the primary endpoint. Start with Abridge for a physician documentation programme in Epic, and with Dragon Copilot when the deployment has to reach nurses and radiologists or when Microsoft already owns the platform relationship.
- Adoption and Epic depth are not close. Best in KLAS for ambient AI in both 2025 and 2026, more than 250 health systems including Kaiser Permanente across roughly 25,000 physicians, Mayo Clinic, Johns Hopkins, Duke and the VA, embedded across Haiku, Canto and Hyperdrive with bidirectional note sync.
- The trust centre answers procurement questions before they are asked: SOC 2 Type 2, HIPAA, CCPA, TX-RAMP, WCAG 2.2 AA, a named sub processor list including OpenAI and Google Cloud, and a dedicated AI section catalogued as training data and bias, AI security and AI monitoring.
- The documentation is pointed at the revenue cycle rather than stopping at the note, which is why this record is cross listed under RCM and prior auth. If the programme is expected to pay for itself through coding and claims, that path is already built rather than promised.
- Role coverage is the widest in the category. Purpose built experiences exist for physicians, nurses and radiologists rather than one clinician product stretched across roles, with the nursing edition converting bedside conversation into structured flowsheet entries. Note that nursing capability is private preview and United States only.
- It tells you where it breaks. The transparency white paper names transcription errors from background noise and overlapping speech, omitted findings and hallucinated details in summarization, a latency threshold that degrades dictation, and model underperformance on dialects and accents not well represented in training data. Almost nobody else in this lane names any of that.
- Reach beyond Epic and a route into other record systems. SMART on FHIR launch for the web application plus a partner developer kit that lets an EHR vendor embed the whole workflow so clinical content never leaves the record, which TruBridge ships natively. Depth outside Epic varies and several capabilities require a separate Dragon Medical One licence.
Side by Side
| Axis | A Abridge |
M Microsoft Dragon Copilot |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Neither vendor publishes a rate card. Third party and reseller figures for Dragon Copilot cluster between roughly 150 and 830 US dollars per provider per month depending on volume, term and existing Microsoft agreements, and are recorded as estimates rather than vendor pricing. The randomized comparison cited here is Lukac et al, NEJM AI, 26 November 2025, in which 238 UCLA Health outpatient physicians across 14 specialties were randomized to DAX Copilot, Nabla or usual care. Abridge was not an arm in that trial, so its efficiency position rests on buyer survey and deployment evidence rather than on a controlled result.